| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 07/20/2005 | CN1641489A Organophotoreceptor with a charge transport material having two epoxidated-carbazolyl groups |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them |
| 07/20/2005 | CN1211361C Fused-ring carboxylic acid derivatives |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919454 Biphenyl-substituted triazines |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919339 ABCA-1 elevating compounds |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein |
| 07/19/2005 | US6919178 Extended tethering approach for rapid identification of ligands |
| 07/14/2005 | WO2005063754A1 Triazole derivatives as vasopressin antagonists |
| 07/14/2005 | WO2005063741A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
| 07/14/2005 | WO2005063737A1 Amidopyrazole derivative |
| 07/14/2005 | WO2005063721A1 Herbicidal pyrimidines |
| 07/14/2005 | WO2005063719A1 Substituted dihydropyrimidinone preparation using polyaniline salt catalyst |
| 07/14/2005 | WO2005063716A1 Imidazoles and their use cck-1 receptor modulators |
| 07/14/2005 | WO2005063707A1 Enantiospecific process for the preparation of paroxetine intermediate |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063244A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 07/14/2005 | WO2005063020A1 Plant growth regulation |
| 07/14/2005 | WO2005030150A3 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF |
| 07/14/2005 | WO2004108085A3 Methods for the protection of memory and cognition |
| 07/14/2005 | WO2004098528A3 Pyrazole-amine compounds useful as kinase inhibitors |
| 07/14/2005 | US20050154042 N-alkyl pyrroles as HMG-CoA reductase inhibitors |
| 07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 07/14/2005 | US20050154038 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 07/14/2005 | US20050154027 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050153997 Fredericamycin derivatives |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one |
| 07/14/2005 | US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153972 Triazole compounds |
| 07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153957 Beta2-adrenoceptor agonists |
| 07/14/2005 | DE10360151A1 New 3-oxo-1-propenyl azo compounds useful as 5-HT receptor antagonists e.g. for treating psychoses, neurological disorders, amyotrophic lateral sclerosis and eating disorders |
| 07/14/2005 | CA2551604A1 Amidopyrazole derivative |
| 07/14/2005 | CA2551549A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 07/14/2005 | CA2551227A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 07/14/2005 | CA2550894A1 Plant growth regulation |
| 07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
| 07/13/2005 | EP1553092A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551830A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
| 07/13/2005 | EP1551829A2 Novel compounds with antibacterial activity |
| 07/13/2005 | EP1551827A1 Piperidine derivatives as ccr5 inhibitors |
| 07/13/2005 | EP1551821A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551801A1 Novel gamma-lactams as beta-secretase inhibitors |
| 07/13/2005 | EP1551404A2 Method of inhibiting angiogenesis |
| 07/13/2005 | EP1551397A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/13/2005 | EP1551384A2 R-nsaid esters and their use |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1178969B1 Gastrin and cholecystokinin receptor ligands |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors |
| 07/13/2005 | CN1639151A Novel azepane derivatives |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/13/2005 | CN1639133A Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638763A Antidepressant |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |